Sunmax Biotechnology Financials
| 4728 Stock | TWD 275.50 2.50 0.90% |
Sunmax |
Understanding current and past Sunmax Biotechnology Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Sunmax Biotechnology's financial statements are interrelated, with each one affecting the others. For example, an increase in Sunmax Biotechnology's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Sunmax Biotechnology's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sunmax Biotechnology Co. Check Sunmax Biotechnology's Beneish M Score to see the likelihood of Sunmax Biotechnology's management manipulating its earnings.
| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| ISIN | TW0004728001 |
| Business Address | No10, Lane 31, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.sunmaxbiotech.com |
| Phone | 886 6 505 3288 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Sunmax Biotechnology without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Sunmax Stock, because this is throwing your money away. Analyzing the key information contained in Sunmax Biotechnology's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Sunmax Biotechnology Key Financial Ratios
There are many critical financial ratios that Sunmax Biotechnology's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Sunmax Biotechnology reports annually and quarterly.Sunmax Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sunmax Biotechnology's current stock value. Our valuation model uses many indicators to compare Sunmax Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sunmax Biotechnology competition to find correlations between indicators driving Sunmax Biotechnology's intrinsic value. More Info.Sunmax Biotechnology Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.59 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Sunmax Biotechnology Co is roughly 1.68 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sunmax Biotechnology's earnings, one of the primary drivers of an investment's value.Sunmax Biotechnology Systematic Risk
Sunmax Biotechnology's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sunmax Biotechnology volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Sunmax Biotechnology correlated with the market. If Beta is less than 0 Sunmax Biotechnology generally moves in the opposite direction as compared to the market. If Sunmax Biotechnology Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sunmax Biotechnology is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sunmax Biotechnology is generally in the same direction as the market. If Beta > 1 Sunmax Biotechnology moves generally in the same direction as, but more than the movement of the benchmark.
Sunmax Biotechnology Thematic Clasifications
Sunmax Biotechnology Co is part of Biotech investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services
This theme covers Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services. Get More Thematic Ideas
| Biotech | View |
Sunmax Biotechnology November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sunmax Biotechnology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sunmax Biotechnology Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sunmax Biotechnology Co based on widely used predictive technical indicators. In general, we focus on analyzing Sunmax Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sunmax Biotechnology's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.44 | |||
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 7.14 | |||
| Value At Risk | (2.24) | |||
| Potential Upside | 2.36 |
Additional Tools for Sunmax Stock Analysis
When running Sunmax Biotechnology's price analysis, check to measure Sunmax Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunmax Biotechnology is operating at the current time. Most of Sunmax Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sunmax Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunmax Biotechnology's price. Additionally, you may evaluate how the addition of Sunmax Biotechnology to your portfolios can decrease your overall portfolio volatility.